It has been shown that MAPK14 plays an important regulatory role in diseases (e.g., pneumonia, acute lung injury, diabetes mellitus) and that inhibition of this pathway is an effective measure to alleviate the level of the inflammatory response and oxidative stress in disease states (Jackson et al., 1998). Here, MAPK14 is linked to susceptibility to pneumonia measurement.